IntraBiotics Pharmaceuticals

Mountain View, United States Founded: 1994 • Age: 32 yrs
Antibiotics for oral mucositis in head-and-neck cancer patients are developed.

About IntraBiotics Pharmaceuticals

IntraBiotics Pharmaceuticals is a Healthcare company based in Mountain View (United States) founded in 1994. Antibiotics for oral mucositis in head-and-neck cancer patients are developed. IntraBiotics Pharmaceuticals has raised $40.4 million across 3 funding rounds from investors including Orbimed, International Bio Medical and New England Capital Partners. Its focus areas include Life Sciences, Dental Disorders and Drugs. Its competitors include OraPharma, Marizyme and Acologix; 2 of its 3 listed competitors have raised funding.

Company details

IntraBiotics Pharmaceuticals was established in 1994 in Mountain View, United States, within the pharmaceuticals sector. Focus is placed on developing antibiotics to address oral mucositis in patients receiving radiotherapy for head-and-neck malignancies. The lead product, iseganan HCl, a synthetic peptide exhibiting broad-spectrum antimicrobial properties, is undergoing a pivotal Phase III clinical trial. Operations center on advancing treatments for radiotherapy-related complications.

  • Headquarters Mountain View, United States
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website intrabiotics.com
Operational Areas
Key Metrics
  • Total Equity Funding
    $40.4M (USD)

    in 3 rounds

  • Latest Funding Round
    $3.5M (USD), Series B

    Mar 2003

  • Investors
    Orbimed

    & 3 more

Funding Insights of IntraBiotics Pharmaceuticals

IntraBiotics Pharmaceuticals has successfully raised a total of $40.4M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $3.5 million completed in March 2003. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $40.4M
  • Total Rounds 3
  • Last Round Series B β€” $3.5M
  • First Round $23M

    (Feb 1999)

  • Investors Count 4

All 3 funding rounds of IntraBiotics Pharmaceuticals with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Mar 2003$3.5MSeries B––
–
Jan 2002$13.9MSeries B––
–
Feb 1999$23MSeries B–International Bio Medical
Valuation history

4 investors in total: 4 institutional.

Investors in IntraBiotics Pharmaceuticals

IntraBiotics Pharmaceuticals has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include Orbimed, International Bio Medical and New England Capital Partners.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Investments are made by OrbiMed in global healthcare innovations across biopharmaceuticals and related fields.
1989orbimed.comNew York, United States
A private investment firm focused on acquiring operating companies.
1991necapitalpartners.comNewton, United States
Portfolio of medical devices
1974int-bio.comAustin, United States
Economic mobility is supported through grants and community programs.
kauffmanfund.orgKansas City, United States
Premium access

Investor details for IntraBiotics Pharmaceuticals

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of IntraBiotics Pharmaceuticals

3 dated milestones of IntraBiotics Pharmaceuticals across 9 years, from founding to its latest funding, stage changes and deals.

  1. Founded IntraBiotics Pharmaceuticals is founded.
  2. Funding First funding round of $23.0M.
  3. Funding Latest funding round, Series B, of $3.5M.

Competitors of IntraBiotics Pharmaceuticals

IntraBiotics Pharmaceuticals has 3 listed competitors in our database, 2 of them funded. They include OraPharma, Marizyme and Acologix.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
orapharma.com1997Bridgewater, United States$16M
Oral health products for treatment and maintenance are developed.
marizyme.com2007Woodstock, United States11
Therapies for chronic wounds, thrombolysis, and dental health are developed.
acologix.com1992Hayward, United States$69.8M13
Therapeutics are developed for kidney and bone metabolic disorders.
Premium access

Detailed competitors of IntraBiotics Pharmaceuticals

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Dental Disorders

3 companies that operate in the same segment as IntraBiotics Pharmaceuticals (Dental Disorders) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Custom 3D printed dental aligners are developed for teeth straightening.
2017New York, New York, United StatesUSD 147.78 M
Invisalign clear aligners and dental products are developed.
1997Tempe, Arizona, United StatesUSD 101 M1,051
Optical equipment for micron-level surface geometry capture is offered.
2011Waltham, Massachusetts, United StatesUSD 16.22 M
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about IntraBiotics Pharmaceuticals

IntraBiotics Pharmaceuticals was founded in 1994 and raised its 1st funding round 5 years after it was founded.

IntraBiotics Pharmaceuticals is headquartered in Mountain View, United States. It is registered at Mountain View, California, United States.

IntraBiotics Pharmaceuticals is a funded company, having raised a total of $40.4M across 3 funding rounds to date. The company's 1st funding round was a Series B of $23M, raised on Feb 1999.

IntraBiotics Pharmaceuticals was established in 1994 in Mountain View, United States, within the pharmaceuticals sector. Focus is placed on developing antibiotics to address oral mucositis in patients receiving radiotherapy for head-and-neck malignancies. The lead product, iseganan HCl, a synthetic peptide exhibiting broad-spectrum antimicrobial properties, is undergoing a pivotal Phase III clinical trial. Operations center on advancing treatments for radiotherapy-related complications.

IntraBiotics Pharmaceuticals's top competitors include Marizyme, Acologix and OraPharma.

IntraBiotics Pharmaceuticals has 4 investors. Key investors include Orbimed, International Bio Medical, New England Capital Partners, and Kauffman Foundation.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available